ANTINUCLEAR ANTIBODY POSITIVITY IS THE BEST PREDICTOR OF RESPONSE TO METHOTREXATE IN JUVENILE IDIOPATHIC ARTHRITIS. ANALYSIS OF THE PRINTO TRIAL

Authors :: Kevin J. Murray
P Munitis Garcia
Ten R. Cate
N Ruperto
V. Gerloni
R Brik
O Arguedas
Dimitrina Mihaylova
Alberto Martini
Angelo Ravelli
NM Wulffraat
S.K. Oliveira
A. Buoncompagni
Carine Wouters
Y Kimura
Angela Pistorio
Source :: JCR: Journal of Clinical Rheumatology. 12:S12-S13
Publication Year :: 2006
Publisher :: Ovid Technologies (Wolters Kluwer Health), 2006.

Subjects :: medicine.medical_specialty
Rheumatology
business.industry
Antinuclear antibody positivity
Internal medicine
medicine
Arthritis
Juvenile
Methotrexate
medicine.disease
business
Gastroenterology
medicine.drug

Full Text Access

Tools